SCHEMBL20786184

SCHEMBL20786184

CCCCCCCCCCC(CCCCCCCC)CCOC(=O)CCCCCCC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.69
TSHR P16473 2/20 0.57
DNM1 Q05193 1/20 0.57
CYP3A4 P08684 1/20 0.57
ATM Q13315 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
MAPT P10636 1/20 0.54
PAM P19021 2/20 0.53
LMNA P02545 4/20 0.53
ALDH1A1 P00352 1/20 0.53
KDM4E B2RXH2 1/20 0.51
DUSP3 P51452 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
PRKCA P17252 1/20 0.49
PRKCE Q02156 1/20 0.49
PRKCQ Q04759 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20774436 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL22821592 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20774442 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20774564 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20774560 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20774559 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20774504 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20774502 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20774505 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM
SCHEMBL20775403 1.00 DGKA (0.69) DGKATSHRDNM1CYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3676240-B1 ESTER COMPOUNDS AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-11-01 EP claimed
CN-111032613-B Ester compound, lubricating oil composition containing the same, and method for producing the same 埃克森美孚化学专利公司 2023-03-28 CN claimed
US-10662388-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-05-26 US claimed
CN-111032613-A Ester compound, lubricating oil composition containing the same, and process for producing the same 埃克森美孚化学专利公司 2020-04-17 CN claimed
EP-3676240-B1 ESTER COMPOUNDS AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-11-01 EP disclosed
EP-3676240-B1 ESTER COMPOUNDS AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-11-01 EP disclosed
EP-3688125-B1 ESTER COMPOUNDS USED AS BASE STOCK IN LUBRICATING OIL COMPOSITIONS EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-25 EP disclosed
CN-111032613-B Ester compound, lubricating oil composition containing the same, and method for producing the same 埃克森美孚化学专利公司 2023-03-28 CN disclosed
EP-3688125-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME ExxonMobil Chemical Patents Inc. (US) 2020-08-05 EP disclosed
EP-3676240-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME ExxonMobil Chemical Patents Inc. (US) 2020-07-08 EP disclosed
CN-111344386-A Ester compound, lubricating oil composition containing same, and method for producing same 埃克森美孚化学专利公司 2020-06-26 CN disclosed
US-10683464-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-06-16 US disclosed
US-10662388-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-05-26 US disclosed
CN-111032613-A Ester compound, lubricating oil composition containing the same, and process for producing the same 埃克森美孚化学专利公司 2020-04-17 CN disclosed
US-20190100711-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US disclosed
US-20190100711-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US disclosed
WO-2019067060-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-04-04 WO disclosed
WO-2019067060-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-04-04 WO disclosed
WO-2019045810-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-03-07 WO disclosed
WO-2019045810-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662388-B2 Ester compounds, lubricating oil compositions containing same and processes for making same GK, NOTUM, EBP DGKA 25/4885TSHR 4498/4885DNM1 2273/4885
US-20190100711-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same ELOVL1, ELOVL5, ELOVL3 DGKA 123/4885TSHR 4701/4885DNM1 1988/4885
US-10683464-B2 Ester compounds, lubricating oil compositions containing same and processes for making same ELOVL1, ELOVL5, ELOVL3 DGKA 123/4885TSHR 4701/4885DNM1 1988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.